Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Laurence

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 4, 2022
Cost of TB prevention and treatment in the Philippines in 2017T P J Capeding, J D Rosa, H Lam, et al.
The Journal of Pathology|December 8, 2006
hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entitiesF Bourdeaut, P Fréneaux, B Thuille, et al.
Journal of Prevention (2022)|August 11, 2025
OveRcoming Adverse ChiLdhood Experiences (ORACLE): A Mixed Methods Intervention Co-design Study to Improve Outcomes for Children and Young People Experiencing or at Risk of AdversityJulia R Forman, Ruth McGovern, Sophie G E Kedzior, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 25, 2022
Cost of TB services: approach and summary findings of a multi-country study (Value TB)S Sweeney, Y V Laurence, L Cunnama, et al.
ESMO Open|April 30, 2021
Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)A Ferrari, D Stark, F A Peccatori, et al.
The Lancet. Global Health|January 31, 2025
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluationSedona Sweeney, Yoko V Laurence, Catherine Berry, et al.
ESMO Open|February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)C Moreau-Bachelard, L Campion, M Toulmonde, et al.
BMJ Public Health|February 28, 2025
Catastrophic expenditure associated with childhood hospitalisation for acute illness in Kenya and Uganda: a cross-sectional studyJulie Jemutai, Rebecca Gathoni Njuguna, Yoko V Laurence, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 16, 2019
Point of care HbA<sub>1c</sub> level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countriesP Huangfu, Y V Laurence, B Alisjahbana, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 4, 2022
Cost of TB prevention and treatment in the Philippines in 2017T P J Capeding, J D Rosa, H Lam, et al.
The Journal of Pathology|December 8, 2006
hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entitiesF Bourdeaut, P Fréneaux, B Thuille, et al.
Journal of Prevention (2022)|August 11, 2025
OveRcoming Adverse ChiLdhood Experiences (ORACLE): A Mixed Methods Intervention Co-design Study to Improve Outcomes for Children and Young People Experiencing or at Risk of AdversityJulia R Forman, Ruth McGovern, Sophie G E Kedzior, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 25, 2022
Cost of TB services: approach and summary findings of a multi-country study (Value TB)S Sweeney, Y V Laurence, L Cunnama, et al.
ESMO Open|April 30, 2021
Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)A Ferrari, D Stark, F A Peccatori, et al.
The Lancet. Global Health|January 31, 2025
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluationSedona Sweeney, Yoko V Laurence, Catherine Berry, et al.
ESMO Open|February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)C Moreau-Bachelard, L Campion, M Toulmonde, et al.
BMJ Public Health|February 28, 2025
Catastrophic expenditure associated with childhood hospitalisation for acute illness in Kenya and Uganda: a cross-sectional studyJulie Jemutai, Rebecca Gathoni Njuguna, Yoko V Laurence, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 16, 2019
Point of care HbA<sub>1c</sub> level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countriesP Huangfu, Y V Laurence, B Alisjahbana, et al.
Pageof 5